Researchers have advanced RNA-targeting CRISPR-Cas13 technology to enable selective modification of desired RNA sequences in living cells. This next-generation gene therapy approach shows promise for treating viral infections and controlling disease-causing gene expression with improved specificity and reduced side effects. CRISPR-Cas13's RNA editing potential represents a new frontier in precision medicine and genetic regulation strategies.